IBDEI3EO ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,57266,1,3,0)
 ;;=3^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,57266,1,4,0)
 ;;=4^J20.9
 ;;^UTILITY(U,$J,358.3,57266,2)
 ;;=^5008195
 ;;^UTILITY(U,$J,358.3,57267,0)
 ;;=J42.^^264^2855^4
 ;;^UTILITY(U,$J,358.3,57267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57267,1,3,0)
 ;;=3^Bronchitis,Chronic
 ;;^UTILITY(U,$J,358.3,57267,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,57267,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,57268,0)
 ;;=J45.909^^264^2855^2
 ;;^UTILITY(U,$J,358.3,57268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57268,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,57268,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,57268,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,57269,0)
 ;;=J45.902^^264^2855^1
 ;;^UTILITY(U,$J,358.3,57269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57269,1,3,0)
 ;;=3^Asthma,Unspec, w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,57269,1,4,0)
 ;;=4^J45.902
 ;;^UTILITY(U,$J,358.3,57269,2)
 ;;=^5008255
 ;;^UTILITY(U,$J,358.3,57270,0)
 ;;=J61.^^264^2855^15
 ;;^UTILITY(U,$J,358.3,57270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57270,1,3,0)
 ;;=3^Pneumoconiosis d/t Asbest & Oth Min Fibers
 ;;^UTILITY(U,$J,358.3,57270,1,4,0)
 ;;=4^J61.
 ;;^UTILITY(U,$J,358.3,57270,2)
 ;;=^5008262
 ;;^UTILITY(U,$J,358.3,57271,0)
 ;;=R09.1^^264^2855^14
 ;;^UTILITY(U,$J,358.3,57271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57271,1,3,0)
 ;;=3^Pleurisy
 ;;^UTILITY(U,$J,358.3,57271,1,4,0)
 ;;=4^R09.1
 ;;^UTILITY(U,$J,358.3,57271,2)
 ;;=^95428
 ;;^UTILITY(U,$J,358.3,57272,0)
 ;;=J84.10^^264^2855^16
 ;;^UTILITY(U,$J,358.3,57272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57272,1,3,0)
 ;;=3^Pulmonary Fibrosis,Unspec
 ;;^UTILITY(U,$J,358.3,57272,1,4,0)
 ;;=4^J84.10
 ;;^UTILITY(U,$J,358.3,57272,2)
 ;;=^5008300
 ;;^UTILITY(U,$J,358.3,57273,0)
 ;;=R91.1^^264^2855^17
 ;;^UTILITY(U,$J,358.3,57273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57273,1,3,0)
 ;;=3^Pulmonay Nodule,Solitary
 ;;^UTILITY(U,$J,358.3,57273,1,4,0)
 ;;=4^R91.1
 ;;^UTILITY(U,$J,358.3,57273,2)
 ;;=^5019707
 ;;^UTILITY(U,$J,358.3,57274,0)
 ;;=B49.^^264^2856^52
 ;;^UTILITY(U,$J,358.3,57274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57274,1,3,0)
 ;;=3^Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,57274,1,4,0)
 ;;=4^B49.
 ;;^UTILITY(U,$J,358.3,57274,2)
 ;;=^5000690
 ;;^UTILITY(U,$J,358.3,57275,0)
 ;;=C49.9^^264^2856^51
 ;;^UTILITY(U,$J,358.3,57275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57275,1,3,0)
 ;;=3^Malig Neop Connective & Soft Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,57275,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,57275,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,57276,0)
 ;;=E11.9^^264^2856^19
 ;;^UTILITY(U,$J,358.3,57276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57276,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,57276,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,57276,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,57277,0)
 ;;=E10.9^^264^2856^18
 ;;^UTILITY(U,$J,358.3,57277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57277,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,57277,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,57277,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,57278,0)
 ;;=D50.0^^264^2856^48
 ;;^UTILITY(U,$J,358.3,57278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57278,1,3,0)
 ;;=3^Iron Deficiency Anemia d/t Blood Loss
 ;;^UTILITY(U,$J,358.3,57278,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,57278,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,57279,0)
 ;;=D62.^^264^2856^6
 ;;^UTILITY(U,$J,358.3,57279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,57279,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
